Loading…
Lisata Therapeutics, Inc. is projected to decline to $0.8148 by 2027, a -22% move from its current price of $1.04. LSTA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.9727 | $1.04 | $1.11 | -0.09% |
| Aug 6 | $0.9456 | $1.04 | $1.14 | -0.18% |
| Aug 7 | $0.9252 | $1.04 | $1.16 | -0.26% |
| Aug 8 | $0.9082 | $1.04 | $1.18 | -0.35% |
| Aug 9 | $0.8933 | $1.04 | $1.20 | -0.44% |
| Aug 10 | $0.8801 | $1.03 | $1.22 | -0.52% |
| Aug 11 | $0.868 | $1.03 | $1.23 | -0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.868 | $1.03 | $1.23 | -0.61% |
| Week 2 | $0.8024 | $1.03 | $1.32 | -1.22% |
| Week 3 | $0.7545 | $1.02 | $1.38 | -1.82% |
| Week 4 | $0.7155 | $1.01 | $1.44 | -2.43% |
| Week 5 | $0.6824 | $1.01 | $1.49 | -3.02% |
| Week 6 | $0.6534 | $1.00 | $1.54 | -3.62% |
| Week 7 | $0.6276 | $0.9963 | $1.58 | -4.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company that engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens.
Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. As of July 21, 2026, Lisata Therapeutics, Inc. operates as a subsidiary of Kuva Labs, Inc.
Lisata Therapeutics, Inc. trades at $1.03 and has a market capitalization of $9.38M. It ranks 4830 in market position.
The current price backdrop is reflected in near-term forecasts, with a 2026 min of $1.03, avg $1.03, max $1.34 and a 0% ROI, signaling a neutral near-term outlook.
The stock shows relatively high volatility, with an annualized volatility of 100%, and notable technical levels: a support at $1.03 and a resistance at $3.75. The 30-day price range spans from $0.6595 to $1.61, indicating recent trading activity within a tight band around the current price.
A major floor 4.8% below — a decisive break under it would weaken the trend.
The nearest floor, 4.8% below — buyers have tended to step in here.
The nearest ceiling, 260.6% above — a clean break opens room to run.
A major ceiling 382.7% above — clearing it would confirm fresh momentum.
Key LSTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LSTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.14 | Sell | $1.23 | Sell |
| MA 10 | $1.75 | Sell | $1.68 | Sell |
| MA 20 | $2.60 | Sell | $2.26 | Sell |
| MA 50 | $3.08 | Sell | $2.89 | Sell |
| MA 100 | $3.60 | Sell | $3.20 | Sell |
| MA 200 | $3.26 | Sell | $3.22 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 14.17 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -113.33 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.22 | Sell |
| ROC (12) | -73.60 | Sell |
| Bollinger %B (20,2) | 0.10 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.70 | Sell |
| Awesome (5,34) | -1.81 | Sell |
| Ultimate (7,14,28) | 4.00 | Buy |
| Momentum (10) | -2.61 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 0.77 | Buy |
| ADX (14) | 39.16 | Sell |
| ATR (14) | 0.16 | Info |
The 30-day technical picture is NEUTRAL, with the RSI(14) at 10.
The SMA50 sits at $3.12 and the SMA200 at $3.26, suggesting the average price path over these timeframes is well above the current level. The stock is currently near support at $1.03 and faces resistance at $3.75.
Over the last 30 days, the price has traded between $0.6595 and $1.61.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.99 | $1.04 | $1.36 | 0% | Neutral | |
| $0.5937 | $0.8148 | $1.21 | -22% | Bearish | |
| $0.6538 | $0.9542 | $1.51 | -8% | Neutral | |
| $0.7361 | $1.13 | $1.88 | +9% | Neutral | |
| $0.7426 | $1.20 | $2.07 | +15% | Neutral | |
| $0.8481 | $1.43 | $2.56 | +37% | Bullish | |
| $0.7066 | $1.24 | $2.30 | +20% | Neutral | |
| $0.5491 | $1.01 | $1.91 | -3% | Neutral | |
| $0.5949 | $1.13 | $2.21 | +9% | Neutral | |
| $0.6291 | $1.25 | $2.49 | +20% | Neutral | |
| $0.6715 | $1.49 | $3.27 | +43% | Bullish | |
| $1.56 | $3.47 | $7.98 | +234% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.99 | $1.04 | $1.30 | +0.00% |
| September 2026 | $0.8071 | $0.981 | $1.24 | -5.67% |
| October 2026 | $0.7789 | $0.9601 | $1.24 | -2.14% |
| November 2026 | $0.8202 | $1.02 | $1.34 | +6.51% |
| December 2026 | $0.8118 | $1.02 | $1.36 | +0.01% |
Click any year to see its month-by-month LSTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The LSTA price prediction for 2026 points to an average of $1.04 (low $0.99, high $1.36) — a potential gain of 0% on today's $1.04. A consolidation phase looks the most probable path here.
In 2027, LSTA is projected to trade between $0.5937 and $1.21, averaging $0.8148 — a potential decline of -22% from today's $1.04. That is -22% versus the projected 2026 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Lisata Therapeutics, Inc.'s 2028 outlook centres on $0.9542, within a $0.6538 to $1.51 range. That is up +17% on the projected 2027 average. That marks a -8% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, LSTA could reach as high as $1.88, with a base case around $1.13 and support toward $0.7361 — roughly +9% from $1.04. Price action looks broadly range-bound.
Expect LSTA to range from $0.7426 to $2.07 through 2030. The $1.20 average target implies a +15% move from current prices. That is up +6% on the projected 2029 average. A consolidation phase looks the most probable path here.
The LSTA price prediction for 2031 points to an average of $1.43 (low $0.8481, high $2.56) — a potential gain of +37% on today's $1.04. Momentum favours further upside here.
In 2032, LSTA is projected to trade between $0.7066 and $2.30, averaging $1.24 — a potential gain of +20% from today's $1.04. That is -13% versus the projected 2031 average. A consolidation phase looks the most probable path here.
Lisata Therapeutics, Inc.'s 2033 outlook centres on $1.01, within a $0.5491 to $1.91 range. That is -19% versus the projected 2032 average. That marks a -3% change versus current levels. Price action looks broadly range-bound.
By 2034, LSTA could reach as high as $2.21, with a base case around $1.13 and support toward $0.5949 — roughly +9% from $1.04. A consolidation phase looks the most probable path here.
Expect LSTA to range from $0.6291 to $2.49 through 2035. The $1.25 average target implies a +20% move from current prices. That is up +10% on the projected 2034 average. Price action looks broadly range-bound.
The LSTA price prediction for 2040 points to an average of $1.49 (low $0.6715, high $3.27) — a potential gain of +43% on today's $1.04. Buyers look set to stay in control over this stretch.
In 2050, LSTA is projected to trade between $1.56 and $7.98, averaging $3.47 — a potential gain of +234% from today's $1.04. That is up +132% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LSTA today (≈ 961.538462 LSTA) could be worth
$3,335.02
+$2,335.02 (+234%) by 2050 · US Dollar
Based on the average projected LSTA price of $3.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LSTAwould be worth at today's price.
$1,000 invested in LSTA on Jul 31, 2025 (≈ 403.225803 LSTA) would be worth
$419.35
-$580.65 (-58.1%) today · 0.42× · US Dollar
Based on a LSTA entry price of $2.48 vs. today's $1.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.67 | $622.75 | -37.7% |
| 1 month ago | $3.36 | $309.52 | -69.0% |
| 3 months ago | $3.13 | $332.27 | -66.8% |
| 6 months ago | $4.56 | $228.07 | -77.2% |
| 1 year ago | $2.48 | $419.35 | -58.1% |
| All time (5.0y) ago | $19.35 | $53.75 | -94.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LSTA forecast.
Our base-case forecast reaches $2.10 around 2050.
Implied market cap at $2.10: $19.12M
The multi-year forecast shows meaningful upside potential in later years, with bullish sentiment returning in 2031, 2040, and 2050.
In 2026 the avg price is $1.03 with a 0% ROI, followed by a 2027 forecast of $0.8106 average and a -21.3% ROI, highlighting a bearish near-term in that year. By 2030 the avg rises to $1.19 with a 15.6% ROI, and in 2031 the avg is $1.42 with a 38.3% ROI, signaling stronger upside in the early 2030s.
Looking further out, 2040 shows an avg price of $1.49 with a 44.3% ROI and a bullish sentiment, while 2050 projects an avg price of $3.42 with a 231.8% ROI and a bullish sentiment. These figures illustrate a path toward higher pricing over the long term, but they remain estimates, not guarantees, and carry inherent uncertainty and risk.
Tap a question to reveal the answer.
The 2026 forecast shows min $1.03, avg $1.03, max $1.34 with ROI 0% and sentiment NEUTRAL.
The 2031 forecast has min $0.8446, avg $1.42, max $2.55 with ROI 38.3% and sentiment BULLISH.
Yes—the 2050 forecast lists a max of $7.86 with ROI 231.8% and sentiment BULLISH.
The forecast shows mixed signals: neutral around 2026, bearish in 2027, then bullish in 2031, 2040, and 2050, with progressively higher projected prices, but these are estimates and not guarantees.
Current price is $1.03 and market cap is $9.38M; the rank is 4830.
Lisata Therapeutics, Inc. Community Discussion
0Share your Lisata Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.